| Primary |
| Renal Transplant |
42.5% |
| Heart Transplant |
7.9% |
| Nephrotic Syndrome |
5.8% |
| Liver Transplant |
5.5% |
| Hypertension |
5.0% |
| Aplastic Anaemia |
4.0% |
| Psoriasis |
3.8% |
| Interstitial Lung Disease |
3.2% |
| Prophylaxis Against Transplant Rejection |
2.9% |
| Lung Transplant |
2.8% |
| Prophylaxis |
2.6% |
| Dermatitis Atopic |
2.5% |
| Stem Cell Transplant |
1.7% |
| Myasthenia Gravis |
1.6% |
| Bone Marrow Transplant |
1.5% |
| Diabetes Mellitus |
1.5% |
| Systemic Lupus Erythematosus |
1.4% |
| Infection Prophylaxis |
1.3% |
| Immunosuppression |
1.3% |
| Pemphigoid |
1.2% |
|
| Death |
10.7% |
| Vomiting |
9.6% |
| Renal Impairment |
9.0% |
| Pyrexia |
8.1% |
| Urinary Tract Infection |
7.9% |
| White Blood Cell Count Increased |
6.0% |
| Sepsis |
5.3% |
| Renal Failure Acute |
4.0% |
| Renal Disorder |
3.9% |
| Renal Failure |
3.8% |
| Thrombocytopenia |
3.5% |
| Proteinuria |
3.5% |
| Transplant Rejection |
3.5% |
| Urine Output Decreased |
3.3% |
| White Blood Cell Count Decreased |
3.3% |
| Surgery |
3.1% |
| Respiratory Failure |
3.1% |
| Thrombotic Microangiopathy |
2.8% |
| Weight Increased |
2.8% |
| Rhabdomyolysis |
2.7% |
|
| Secondary |
| Renal Transplant |
38.3% |
| Heart Transplant |
13.0% |
| Hypertension |
6.2% |
| Prophylaxis |
5.3% |
| Dermatitis Atopic |
3.6% |
| Nephrotic Syndrome |
3.2% |
| Psoriasis |
3.0% |
| Infection Prophylaxis |
2.7% |
| Product Used For Unknown Indication |
2.5% |
| Prophylaxis Against Transplant Rejection |
2.4% |
| Lung Transplant |
2.4% |
| Aplastic Anaemia |
2.4% |
| Bone Marrow Transplant |
2.3% |
| Drug Use For Unknown Indication |
2.2% |
| Immunosuppression |
2.1% |
| Hyperlipidaemia |
1.7% |
| Liver Transplant |
1.7% |
| Gastritis Prophylaxis |
1.6% |
| Myelodysplastic Syndrome |
1.6% |
| Constipation |
1.5% |
|
| Vomiting |
11.6% |
| Pyrexia |
8.7% |
| White Blood Cell Count Increased |
7.7% |
| Renal Impairment |
7.6% |
| Cardiac Failure |
6.4% |
| Sepsis |
6.4% |
| Urinary Tract Infection |
6.3% |
| Renal Disorder |
5.4% |
| Thrombocytopenia |
4.5% |
| Renal Failure Acute |
3.8% |
| Weight Decreased |
3.8% |
| Urine Output Decreased |
3.7% |
| Respiratory Failure |
3.5% |
| White Blood Cell Count Decreased |
3.1% |
| Cerebral Atrophy |
3.1% |
| Postresuscitation Encephalopathy |
3.1% |
| Renal Failure |
3.0% |
| Tracheobronchitis |
2.8% |
| Weight Increased |
2.8% |
| Stomatitis |
2.8% |
|
| Concomitant |
| Prophylaxis |
15.8% |
| Product Used For Unknown Indication |
15.2% |
| Drug Use For Unknown Indication |
11.7% |
| Renal Transplant |
9.8% |
| Behcet's Syndrome |
6.2% |
| Hypertension |
5.8% |
| Psoriasis |
4.5% |
| Juvenile Arthritis |
4.0% |
| Aplastic Anaemia |
3.6% |
| Prophylaxis Against Transplant Rejection |
3.3% |
| Rheumatoid Arthritis |
3.1% |
| Heart Transplant |
2.7% |
| Idiopathic Pulmonary Fibrosis |
2.2% |
| Immunosuppression |
2.0% |
| Idiopathic Thrombocytopenic Purpura |
2.0% |
| Infection Prophylaxis |
1.9% |
| Pustular Psoriasis |
1.8% |
| Castleman's Disease |
1.6% |
| Prophylaxis Against Gastrointestinal Ulcer |
1.5% |
| Iron Overload |
1.5% |
|
| Vomiting |
12.9% |
| White Blood Cell Count Decreased |
12.0% |
| Pyrexia |
10.7% |
| Renal Impairment |
6.1% |
| Hepatic Function Abnormal |
5.0% |
| Platelet Count Decreased |
5.0% |
| Subcutaneous Abscess |
4.3% |
| Interstitial Lung Disease |
4.0% |
| Thrombocytopenia |
4.0% |
| Myelodysplastic Syndrome |
3.7% |
| Pneumonia |
3.7% |
| Weight Decreased |
3.7% |
| Nausea |
3.5% |
| Rhabdomyolysis |
3.5% |
| Death |
3.3% |
| Uveitis |
3.2% |
| Histiocytosis Haematophagic |
3.0% |
| Sepsis |
2.9% |
| Thyroid Cancer |
2.9% |
| Anaemia |
2.7% |
|
| Interacting |
| Heart Transplant |
24.7% |
| Renal Transplant |
12.2% |
| Bronchopulmonary Aspergillosis |
7.2% |
| Psoriasis |
5.8% |
| Product Used For Unknown Indication |
5.5% |
| Hypertension |
5.0% |
| Nephrotic Syndrome |
4.6% |
| Chronic Myeloid Leukaemia |
4.3% |
| Acute Myeloid Leukaemia |
3.8% |
| Hypercholesterolaemia |
3.8% |
| Psychotic Disorder |
3.4% |
| Bone Marrow Failure |
2.9% |
| Endocarditis Bacterial |
2.9% |
| Chronic Myeloid Leukaemia Transformation |
2.4% |
| Drug Use For Unknown Indication |
2.4% |
| Dyslipidaemia |
2.4% |
| Prophylaxis |
1.9% |
| Lung Infection |
1.7% |
| Type 1 Diabetes Mellitus |
1.7% |
| Cardiac Failure |
1.4% |
|
| Drug Interaction |
13.9% |
| Vomiting |
13.9% |
| Rhabdomyolysis |
10.4% |
| Immunosuppressant Drug Level Decreased |
7.8% |
| Renal Impairment |
6.1% |
| Myocardial Infarction |
5.2% |
| Renal Failure Acute |
5.2% |
| Bronchopulmonary Aspergillosis |
3.5% |
| Coronary Artery Stenosis |
3.5% |
| Myalgia |
3.5% |
| Potentiating Drug Interaction |
3.5% |
| Renal Cancer |
3.5% |
| Vascular Operation |
3.5% |
| Blood Magnesium Decreased |
2.6% |
| Toxicity To Various Agents |
2.6% |
| Transplant Rejection |
2.6% |
| Varicella |
2.6% |
| Weight Decreased |
2.6% |
| Eating Disorder |
1.7% |
| Heart Rate Decreased |
1.7% |
|
